Introduction {#S1}
============

Microbial production has become a dominant method to generate various substances, such as amino acids ([@B32]), organic acids ([@B1]), and vitamins ([@B2]). To obtain a large number of value-added compounds, the conventional mutagenesis strategy ([@B38]; [@B28]) has been regarded as a desired approach in the past few years, however, it is hard to obtain the hyperproducing strains among a large number of mutant strains. Recently, advances in the metabolic engineering strategies ([@B13]) have enabled rationally designed microorganisms, and considerable attention has been focused on the modification of enzymes in metabolic pathways ([@B25]). In one such example, based on the *Corynebacterium glutamicum* AR1 strain, removal of the regulatory repressors of the arginine operon, optimization of the NADPH level, and disruption of the [L]{.smallcaps}-glutamate exporter allowed the strain to produce 92.5 g L^--1^ of [L]{.smallcaps}-arginine in a 5-L bioreactor ([@B21]). This has led to successful overproduction of quantities of target compounds. However, because of the widely used of this approach, the [L]{.smallcaps}-arginine production of strains has reached a bottleneck. Therefore, random mutagenesis is still an effective strategy for improving metabolites production. To overcome the defects of conventional screening methods, biosensors are routinely employed to detect the metabolites production and obtain the hyperproducing strains in a short time. This is mainly achieved by a transcription factor (TF)-based system with the output of reporter genes, including fluorescence intensity or antibiotic resistance ([@B16]; [@B15]).

Naturally, microorganisms have their own regulatory system to maintain the metabolic balance. Based on the characteristics of the binding of a protein to a molecule and the variability of protein conformation, the function and activity can be used of controlling the expression of downstream genes ([@B14]). The TF is a good example, exhibiting specific binding to target metabolites and up- or down-regulation of gene expression by changing structure. The LysG TF in the LysR family of *C. glutamicum* is a typical example of high-throughput screening. Based on the LysG TF, which can sense [L]{.smallcaps}-arginine, [L]{.smallcaps}-lysine, and [L]{.smallcaps}-histidine and interact with the corresponding promoter of *lysE*, the biosensor of pSenLys-Spc has been successfully constructed in *C. glutamicum* ([@B24]). In addition, the regulatory protein FadR, which is responsive to acyl-CoA, has been employed for a dynamic control of biosynthetic pathways ([@B41]). A QdoR-based biosensor was also applied to monitor kaempferol production in single cells by flow cytometry ([@B27]). Inspired by these features, TFs can be developed as the main elements to construct whole-cell biosensors that can regulate the transcription level of reporter genes in response to specific metabolites ([@B26]).

[L]{.smallcaps}-Arginine production in *C. glutamicum* is organized by an *arg* cluster of *argCJBDFRGH* that can be classified into *argCJBDFR* and *argGH* operons. The two operons regulate most enzymes that convert [L]{.smallcaps}-glutamate into [L]{.smallcaps}-arginine, and then, transcription is initiated by their respective *argC* and *argG* promoters. Furthermore, ArgR is considered a negative regulator that represses the transcription of *argCJBDFR* in response to high [L]{.smallcaps}-arginine concentration and recognizes its binding motifs on the *argC* promoter ([@B5]). The *argC* promoter is at the first position of the *arg* cluster and can influence the expression of downstream genes ([@B39]). However, the ArgR repressor cannot associate with the *argG* promoter because it is not responsible for *argGH* ([@B30]). Some strategies have been used to improve [L]{.smallcaps}-arginine production in *Corynebacterium crenatum* SYPA5-5 ([@B36]; [@B10]). An engineered strain, Cc6, was constructed, which involved removal of regulatory repressors of the [L]{.smallcaps}-arginine operon, optimization of the NADPH level, disruption of the [L]{.smallcaps}-glutamate exporter, and flux optimization of rate-limiting [L]{.smallcaps}-arginine biosynthetic reactions ([@B17]).

In this study, we attempted to utilize ArgR protein and the corresponding promoter of *argC* to construct the ARG-Select biosensor. This biosensor was applied in *C. crenatum* SYPA5-5 and its engineered strain Cc6. Because of the lethal effects of *sacB* in the presence of 10% sucrose ([@B8]; [@B22]), it was chosen as the reporter gene to reflect the intracellular [L]{.smallcaps}-arginine concentration. This biosensor provides a high-throughput screening method based on the output of cell growth. Meanwhile, the fluorescence intensity of *gfp* was also used to monitor the change in [L]{.smallcaps}-arginine production in cells, which makes intracellular [L]{.smallcaps}-arginine concentration visible, and the accuracy of the biosensor system was demonstrated. Finally, both the [L]{.smallcaps}-arginine production of the two strains was increased, indicating that the application of the ARG-Select biosensor is an efficient method to obtain desired mutants in good yields.

Materials and Methods {#S2}
=====================

Strains and Plasmids {#S2.SS1}
--------------------

All the strains, plasmids and their sources are listed in [Table 1](#T1){ref-type="table"}. The strain of *C. crenatum* SYPA5-5 (CGMCC No. 0890) was obtained by UV and EMS mutagenesis, and it could produce [L]{.smallcaps}-arginine (30 g L^--1^) in shake-flask fermentation under optimal culture conditions ([@B35]). The Cc6 strain was obtained by system pathway engineering from *C. crenatum* SYPA5-5, and its [L]{.smallcaps}-arginine production could reach 87.3 g L^--1^ in fed-batch fermentation ([@B17]). The *C. glutamicum*/*E. coli* shuttle vector of pDXW-10 was used for *C. glutamicum* expression ([@B34]). The reporter gene of *sacB* encodes the *Bacillus subtilis* levansucrase, and *sacB* expression is lethal to strains in the presence of 10% sucrose ([@B22]).

###### 

Strains and plasmids used in this study.

  **Strains/plasmids**   **Characteristics**                                                                                           **Resource**
  ---------------------- ------------------------------------------------------------------------------------------------------------- ---------------------
  **Strains**                                                                                                                          
  *E. coli*                                                                                                                            
  JM109                  A model wild type *E. coli*                                                                                   Lab stored
  *EcoPC-sacB*           *E. coli* JM109 with *PC*-*sacB* plasmid                                                                      This work
  ***C. glutamicum***                                                                                                                  
  ATCC 13032             A model wild type *C. glutamicum*                                                                             Lab stored
  *Cg*Δ*argR*            *C. glutamicum* ATCC 13032 with deletion of *argR* gene                                                       Lab stored
  *CgPC-sacB*            *C. glutamicum* ATCC 13032 with *PC*-*sacB* plasmid                                                           This work
  ***C. crenatum***                                                                                                                    
  SYPA5-5                A model wild type *C. crenatum*                                                                               Lab stored
  Cc6                    An [L]{.smallcaps}-arginine high-producing *C. crenatum* SYPA5-5 with multis metabolic engineering methods    Lab stored ([@B17])
  *CcPC-sacB*            *C. crenatum* SYPA5-5 with *PC*-*sacB* plasmid                                                                This work
  **Plasmids**                                                                                                                         
  pDXW-10                *E. coli*--*C. glutamicum* shuttle vector, Km^r^ or Amp^r^                                                    Lab stored ([@B34])
  *PC-sacB*              *argC* promoter linked with *sacB* by overlap extension PCR and ligated on plasmid pDXW-10, Km^r^ or Amp^r^   This work
  *PC-gfp*               *argC* promoter linked with *gfp* by overlap extension PCR and ligated on plasmid pDXW-10, Km^r^ or Amp^r^    This work
  pSenArg-*sacB*         *argR* gene ligated on plasmid *PC-sacB*, Km^r^ or Amp^r^                                                     This work
  pSenArg-*gfp*          *argR* gene ligated on plasmid *PC-gfp*, Km^r^ or Amp^r^                                                      This work

The ARG-Select Biosensor Plasmid Construction {#S2.SS2}
---------------------------------------------

All of the primers and restriction enzymes are listed in [Table 2](#T2){ref-type="table"}. Primers were synthesized by Genewiz (Suzhou, China). The restriction enzymes, DNA polymerase of PrimeSTAR HS, and T4 DNA ligase were purchased from TaKaRa (Dalian, China). Using genomic DNA from *C. glutamicum* ATCC 13032 as a template, the gene encoding ArgR was amplified with *argR*-F and *argR*-R primers. The *sacB* gene was amplified from the pK18*mobsacB* plasmid with *sacB*-F and *sacB*-R primers, and the *gfp* gene was obtained by PCR from the pDXW-10*gfp* plasmid using the *gfp*-F and *gfp*-R primers. The native promoter of *tac-M* was replaced by the P*~*lac*~* promoter at the *Bam*HI and *Eco*RI sites, and the P*~*lac*~* promoter was amplified with the P*~*lac*~*-F and P*~*lac*~*-R primers. The *argC* promoter was linked with *sacB* and *gfp* by overlap extension PCR and digested with *Hin*dIII, *Afl*II, *Pst*I, and *Bgl*II, and the PCR products were ligated into the pDXW-10 plasmid. Briefly, to construct the biosensor plasmids of pSenArg-*sacB* and pSenArg-*gfp*, the *argR* gene was ligated into the *PC*-*sacB* and *PC*-*gfp* plasmids using *Eco*RI and *Not*I. Finally, the recombinant plasmids were transformed into *C. glutamicum* ATCC 13032 and *C. crenatum* SYPA5-5.

###### 

Primers used in this study.

  **Primers**      **Sequences**                                    **Restriction enzymes**
  ---------------- ------------------------------------------------ -------------------------
  *PC*-*sacB*-F1   CCC**AAGCTT**AAATTCATG CTTTTACCCACTTGC           *Hin*dIII site
  *PC*-*sacB*-R1   GCAAACTTTTTGATGTTCA TAGTTACACCATACACG            Fusion overlap
  *PC*-*sacB*-F2   CGTGTATGGTGTAACTAT GAACATCAAAAAGTTTG             Fusion overlap
  *PC*-*sacB*-R2   CCC**ACATGT**TTATT TGTTAACTGTTAATTGTCC           *Afl*II site
  *argR*-F         CG**GAATTC**ATGTCCCTTG GCTCAACCCC                *Eco*RI site
  *argR*-R         ATTT**GCGGCCGC**TTAAG TGGTGCGCCCGCTGAG           *Not*I site
  P*~*lac*~*-F     CG**GGATCC**TAATGGA TTTCCTTACG                   *Bam*HI site
  P*~*lac*~*-R     CG**GAATTC**ATAATAA CCGGGCAGGCC                  *Eco*RI site
  *PC*-*gfp*-F1    GA**AGATCT**AAAT TCATGCTTTTACCCACTTGC            *Bgl*II site
  *PC*-*gfp*-R1    GTTCTTCTCCCTTAC CCATAGTTACA CCATACACGTTATGCATG   Fusion overlap
  *PC*-*gfp*-F2    CATGCATAACGTGTATG GTGTAACTATG GGTAAGGGAGAAGAAC   Fusion overlap
  *PC*-*gfp*-R2    AA**CTGCAG**TTAT TTGTATAGTTCATCCATG              *Pst*I site

Bold sequences highlight recognition sites for restriction enzymes.

Quantitative Real-Time PCR Analysis {#S2.SS3}
-----------------------------------

Strains were cultivated at 30°C and 180 rpm and induced by 0.05 mM IPTG when the OD~600~ reached 0.5. Cells were harvested by centrifugation at 12,000 rpm, at 4°C for 2 min, suspended in 100 μL TE buffer containing 20 μL lysozyme (150 mg L^--1^) and incubated for 30 min. Total RNA was purified using a MasterPure^TM^ RNA purification kit (Vazyme, China). The first strand cDNAs were synthesized by HiScript^®^II Q RT SuperMix (Vazyme, China) using total RNA (0.5 μg). For RT-qPCR, the 16S rRNA was chosen as the endogenous control. The reaction mixture was prepared in a qPCR tube and consisted of 10 μL of 2× ChamQ Universal SYBR qPCR Master Mix, 0.4 μL of forward and reverse primers (10 μM each) respectively, 1.0 μL of cDNA, and 8.2 μL of ddH~2~O. The RT-qPCR was performed on a Bio-Rad CFX96 Manager PCR system (Bio-Rad, United States) using the following parameters: 95°C for 30 s, followed by 40 cycles of denaturation at 95°C for 10 s and 60°C for 30 s and extension at 72°C for 20 s. The 2^--ΔΔ*Ct*^ method was applied to analyze the data, which were normalized to the transcription level of 16S rRNA.

Medium and Growth Conditions {#S2.SS4}
----------------------------

Both *Corynebacterium* sp. strains were first cultivated at 30°C in broth medium (BHI) with 50 μg mL^--1^ of kanamycin or ampicillin added. The preliminary screening agar medium was [L]{.smallcaps}-arginine production fermentation medium (glucose 25 g L^--1^, yeast extract 10 g L^--1^, (NH~4~)~2~SO~4~ 40 g L^--1^, KH~2~PO~4~ 1.5 g L^--1^, KCl 1 g L^--1^, MgSO~4~.7H~2~O 0.5 g L^--1^, FeSO~4~.7H~2~O 0.02 g L^--1^, and MnSO~4~.H~2~O 0.02 g L^--1^) containing 10% sucrose and 0.05 mM IPTG. Three days later, the mutant colonies were inoculated into 24-deep-well plates with 3 mL of fermentation medium without sucrose, and they were cultivated for 48 h until the cell's concentration reached an OD~600~ = 3.5--4.0. For shake-flask fermentation, mutant strains were activated on fermentation agar plates for 24 h and inoculated in 10 mL of seed medium (BHI). Then, 1.5 mL of seed culture was transferred into 30 mL of fermentation medium (glucose 150 g L^--1^, yeast extract 10 g L^--1^, (NH~4~)~2~SO~4~ 40 g L^--1^, KH~2~PO~4~ 1.5 g L^--1^, KCl 1 g L^--1^, MgSO~4~.7H~2~O 0.5 g L^--1^, FeSO~4~.7H~2~O 0.02 g L^--1^, MnSO~4~.H~2~O 0.02 g L^--1^, and CaCO~3~ 20 g L^--1^) in 250-mL shake flasks and cultivated at 220 rpm for 96 h. Subsequently, the yield of [L]{.smallcaps}-arginine was measured. Repeated fermentation of mutant strains was required to ensure genetic stability.

ARTP Mutagenesis {#S2.SS5}
----------------

Before treating with atmospheric and room temperature plasma (ARTP) mutagenesis, cells were cultivated to the mid and late stages of logarithmic growth. The cells were washed twice with sterile saline and diluted to an OD~600~ = 0.2--0.3. Mutagenesis was performed using the ARTP mutation breeding system (Si Qing Yuan Biotechnology Co., Ltd., China). First, 10 μL of cell culture was placed on a piece of metal slide and put on the minidisc. The main parameters included the input power (100 W), ventilation flow rate (10 L min^--1^), and the distance between the sample plate and ion generator (2 mm).

Cells were treated by an ion beam for 30 s. Then, the sheet iron with 10 μL of mutagenized cells was placed into 990 μL of sterile saline. Finally, the cells were diluted and spread on the fermentation medium plates containing 10% sucrose. After incubation at 30°C for 3 days, the numbers of control colonies (A) and surviving colonies (B) were counted and the lethality rates were calculated with the following equation: (A − B)/A × 100%.

Flow Cytometry {#S2.SS6}
--------------

Before cells were analyzed by flow cytometry, 10 μL of mutagenized cells with the reporter gene of *gfp* were cultivated for 6 h in 1.0 mL of fermentation medium containing 50 μg mL^--1^ of kanamycin or ampicillin for cells' recovery. Afterward, 100 μL of the cell culture was incubated in 10 mL of fresh medium and induced by IPTG until the OD~600~ reached 0.5. Then, the cells were washed twice with phosphate buffer (pH 7.4) and diluted to OD~600~ = 0.1.

Fluorescence sorting of cells was performed by a FACSAria II flow cytometer (Becton Dickinson, San Jose, United States) using an excitation wavelength of 488 ± 20 nm and an emission wavelength of 520 ± 20 nm at a sample pressure of 70 psi. The forward-scatter characteristics (FSC) and side-scatter characteristics (SSC) were detected with a 488-nm laser. Non-fluorescent cells of *C. crenatum* SYPA5-5 cells were used to exclude the background for cell sorting. Two gates with different fluorescence intensity were circled out based on pre-analysis of mutagenized cells, and four-way purity was used as the precision mode for cell sorting with a threshold rate of up to 6,000 events s^--1^. Data were analyzed using FlowJo v10.0.7 analysis software (Tree Star, Ashland, United States).

Fed-Batch Fermentation {#S2.SS7}
----------------------

Fed-batch fermentation was carried out in 5-L fermenters (BIOTECH-5BG, Baoxing Co., China). Strains were first activated on an agar plate (glucose 30 g L^--1^, NaCl 10 g L^--1^, peptone 10 g L^--1^, yeast extract 5 g L^--1^, agar 20 g L^--1^, corn steep liquor 25 g L^--1^, pH 7.0) for 24 h. Single colonies were inoculated into seed medium (glucose 40 g L^--1^, corn steep liquor 50 g L^--1^, K~2~HPO~4~ 1.5 g L^--1^, MgSO~4~.7H~2~O 0.5 g L^--1^, CaCO~3~ 1 g L^--1^, urea 1 g L^--1^, (NH~4~)~2~SO~4~ 10 g L^--1^, pH 7.0) and cultivated at 30°C and 180 rpm for 24 h until the OD~600~ = 16--18. The seed culture was then transferred into 1.5 L of fermentation medium (glucose 40 g L^--1^, corn steep liquor 50 g L^--1^, (NH~4~)~2~SO~4~ 30 g L^--1^, KH~2~PO~4~ 2 g L^--1^, MgSO~4~.7H~2~O 0.5 g L^--1^, urea 1 g L^--1^, molasses 10 g L^--1^, pH 7.0) at 1:100 vol/vol. The feed medium (corn steep liquor 120 g L^--1^, molasses 120 g L^--1^, KH~2~PO~4~ 12 g L^--1^, MgSO~4~.7H~2~O 3 g L^--1^, pH 7.0) was fed into the fermenters when the concentration of glucose was less than 20 g L^--1^. The pH was controlled at 7.0 by 50% NH~3~.H~2~O, and the agitation speed was 600 rpm.

Analytical Methods of [L]{.smallcaps}-Arginine {#S2.SS8}
----------------------------------------------

The production of [L]{.smallcaps}-arginine in 24-deep-well plates was measured by a modified Sakaguchi reagent spectrophotometric method ([@B19]; [@B20]). This method depends on the guanidyl on [L]{.smallcaps}-arginine, which can produce a purple substance with a mixture of naphthol and diacetyl in an alkaline medium. The reaction mixture consisted of 1 mL of sample solution, 4 mL of 0.375 M NaOH and 1 mL of color developing agent (5 g of 1-naphthol and 2.5 mL of 1% diacetyl dissolved in 100 mL normal propyl alcohol). The reaction was incubated at 30°C for 30 min, and the absorbance was measured at 520 nm.

For the shake-flask and fed-batch fermentation, cell culture was centrifuged at 8,000 rpm for 1 min, and 1 mL of culture supernatant was treated with 1 mL of 0.5 mol L^--1^ NaHCO~3~ and 150 μL of 1% DNFB-acetonitrile. Then, the mixture was heated at 60°C in darkness for 60 min. [L]{.smallcaps}-Arginine production was detected by using an HPLC system, and the separation was achieved by using a platisil 5 μm ODS, 250 × 4.6 mm C18 column. The mobile phase consisted of 0.1 mol L^--1^ NaAc (pH 6.4)-acetonitrile (86:14), with a flow rate of 1.0 mL min^--1^, injection volume of 10 μL, column temperature of 30°C, and detection wavelength of 360 nm.

Structure Modeling {#S2.SS9}
------------------

Homology modeling of the ArgR protein was carried out with SWISS-MODEL^[1](#footnote1){ref-type="fn"}^ using the structure of *Mycobacterium tuberculosis* (PDB: 6A2Q) as a template. The binding of the [L]{.smallcaps}-arginine molecule to the ArgR protein was included in the structure. The model was assembled primarily as a tool to predict mutation sites. Model observation, image processing, and correlation analyses regarding the binding pocket of ArgR protein were performed by PyMOL program ([@B9]; [@B11]).

Results {#S3}
=======

Design and Construction of the ARG-Select Biosensor {#S3.SS1}
---------------------------------------------------

We proposed to improve the [L]{.smallcaps}-arginine production in *C. crenatum* SYPA5-5 and its system metabolic engineered strain Cc6 by constructing an [L]{.smallcaps}-arginine biosensor. Referring to the reported pSenLys-Spc biosensor system ([@B24]), we first attempted to construct a similar system in *C. crenatum* SYPA5-5 to obtain hyper-arginine producers. Indeed, the [L]{.smallcaps}-Lys/[L]{.smallcaps}-Arg exporter LysG could be transported to [L]{.smallcaps}-lysine and [L]{.smallcaps}-arginine, and it was regulated by the LysR regulator. In *C. crenatum* SYPA5-5, the pSenLys-Spc biosensor did not respond to the high [L]{.smallcaps}-arginine concentration as well as expected. Due to this finding, we speculated that an important regulator of ArgR was involved in the [L]{.smallcaps}-arginine synthesis in *C. glutamicum*.

Our biosensor system utilized the ArgR protein from *C. glutamicum* to downregulate the *argC* promoter in response to high [L]{.smallcaps}-arginine concentration, which can be reflected by the reporter gene of *sacB*. Hence, the cell can only survive on 10% sucrose when the [L]{.smallcaps}-arginine concentration reaches a high value, and we named the biosensor as "ARG-Select" ([Figure 1](#F1){ref-type="fig"}). The gene encoding ArgR was driven by the inducible P*~*lac*~* promoter, and the expression of the reporter gene was controlled by the *argC* promoter. The P*~*lac*~* promoter was induced by IPTG in the preliminary screening plate containing 10% sucrose, and [L]{.smallcaps}-arginine production was measured in the fermentation medium without IPTG added. Moreover, to demonstrate the effectiveness of this system, the *gfp* gene was also employed to monitor the [L]{.smallcaps}-arginine concentration by fluorescence intensity. Based on the results, the [L]{.smallcaps}-arginine concentration can be converted into cell survival and fluorescence signals of the ARG-Select biosensor.

![Design and construction of the ARG-Select biosensor. **(A)** No cells grew on 10% sucrose plate at low [L]{.smallcaps}-arginine concentration. **(B)** Cells grew on 10% sucrose plate with increased [L]{.smallcaps}-arginine concentration.](fbioe-08-00175-g001){#F1}

Sensitivity of the ARG-Select Biosensor to Extracellular [L]{.smallcaps}-Arginine {#S3.SS2}
---------------------------------------------------------------------------------

To evaluate the feasibility of the ARG-Select biosensor, the cell response to the [L]{.smallcaps}-arginine concentration was investigated. Different [L]{.smallcaps}-arginine concentrations ranging from 0 to 100 mM were added to the BHI medium plate containing 0.05 mM IPTG and 10% sucrose. Strains were cultivated on these plates by streaking inoculation, and the growth performance was observed after 3 days. A different growth status was observed on the increased [L]{.smallcaps}-arginine concentration plates ([Figure 2A](#F2){ref-type="fig"}). No surviving cells were found on the 0 mM [L]{.smallcaps}-arginine plate, and only a few cells could grow when 10 mM [L]{.smallcaps}-arginine was added. A clear increase in cell growth was noted when the [L]{.smallcaps}-arginine concentration reached 60 mM. Complete growth of cells was observed at [L]{.smallcaps}-arginine concentrations of 60, 80, and 100 mM. For the *gfp*-based ARG-Select biosensor, the fluorescence was decreased with increased [L]{.smallcaps}-arginine concentrations ([Figures 2B,C](#F2){ref-type="fig"}), and cells' fluorescence was undetectable at 40 mM [L]{.smallcaps}-arginine.

![**(A)** Growth performance of strains on 10% sucrose plates at different [L]{.smallcaps}-arginine concentrations. From left to right: 0, 10, 20, 40, 60, 80, and 100 mM [L]{.smallcaps}-arginine. The positive control (harboring an empty plasmid) is shown in the top left corner, the negative control (harboring the *PC-sacB* plasmid) is shown at the bottom, and the strain carrying the pSenArg-*sacB* plasmid is shown in the top right corner. The growth performance of strains improved as [L]{.smallcaps}-arginine concentration increased. **(B)** Fluorescence microscope images of the strain carried the pSenArg-*gfp* plasmid with 0, 10, 20, 40, 60, 80, and 100 mM [L]{.smallcaps}-arginine concentrations. **(C)** FACS analysis of the fluorescence of strain carried pSenArg-*gfp* plasmid at different [L]{.smallcaps}-arginine concentration. **(D)** Relative transcription level of the *sacB* and *gfp* reporter genes at different [L]{.smallcaps}-arginine concentrations.](fbioe-08-00175-g002){#F2}

Finally, RT-qPCR was performed on the recombinant ARG-Select biosensor to analyze the change in reporter gene expression at different [L]{.smallcaps}-arginine concentrations. The expression levels of *sacB* and *gfp* were decreased by 2.13- and 2.38-fold at 10 mM [L]{.smallcaps}-arginine and 5.02- and 5.88-fold at 60 mM [L]{.smallcaps}-arginine ([Figure 2D](#F2){ref-type="fig"}). However, at 80 and 100 mM [L]{.smallcaps}-arginine, the strains exhibited the maximum growth, and the fluorescence intensity decreased to the lowest level. These results demonstrate a correlation between the cell growth or fluorescence and [L]{.smallcaps}-arginine concentration (0--60 mM), and the ARG-Select biosensor system exhibits a sensitive response to different [L]{.smallcaps}-arginine concentrations.

Verification of ARG-Select Biosensor Based on Reporter Gene of *gfp* {#S3.SS3}
--------------------------------------------------------------------

To examine the effectiveness of the ARG-Select biosensor, the *gfp*-based biosensor was used to further verify the relationship between fluorescence intensity and [L]{.smallcaps}-arginine production ([Figure 3](#F3){ref-type="fig"}). The strain that carried the pSenArg-*gfp* plasmid was treated by ARTP mutagenesis and then analyzed by FACS. The mutagenized cells were sorted into two gates depending on whether the fluorescence was higher (P1) or lower (P2) than the control. Subsequently, cells in the two gates were collected and spread on agar plate with 50 μg mL^--1^ of kanamycin or ampicillin added. We randomly selected 200 strains from each gate and determined the [L]{.smallcaps}-arginine production in 24-deep-well plates for 48 h. Cells in P1 showed strong fluorescence and could produce 1.91 g L^--1^ of [L]{.smallcaps}-arginine on average; the [L]{.smallcaps}-arginine production of cells in P2 showed low fluorescence, and the cells could produce 2.48 g L^--1^ of [L]{.smallcaps}-arginine. The difference of [L]{.smallcaps}-arginine production between P1 and P2 cells was statistically significant (*P* \< 0.01). Most of the weak cells could not be further identified and isolated by FACS. This result indicated that the fluorescence in a *gfp*-based biosensor system was capable of predicting the [L]{.smallcaps}-arginine yield of strains. The obvious difference of the [L]{.smallcaps}-arginine production between the strains in the two gates demonstrated the ability of the ARG-Select biosensor.

![**(A)** The process of ARG-Select biosensor construction and [L]{.smallcaps}-arginine hyperproducing strains' selection. **(B)** FACS analysis of the strain that carried the pSenArg-*gfp* plasmid. The non-mutagenized parent strain is on the left, and the mutagenized strain is on the right. Cells with strong fluorescence are in gate P1, and cells with weak fluorescence are in gate P2.](fbioe-08-00175-g003){#F3}

The Applicability of the ARG-Select Biosensor System {#S3.SS4}
----------------------------------------------------

*Corynebacterium crenatum* SYPA5-5 is a mutant strain that could produce 30 g L^--1^ [L]{.smallcaps}-arginine in our study. Previously, it was reported that a negative mutation (C → T) of *argR* occurred in *C. crenatum* SYPA5-5 that led to obviously increased expression of the *argC*--*argH* cluster ([@B35]). To investigate the ArgR background expression of the ARG-Select biosensor in different strains, the *PC-sacB* plasmid was constructed, and strains were inoculated on plates containing 10% sucrose. As shown in [Figure 4A](#F4){ref-type="fig"}, the expression of *sacB* was first verified in *E. coli*, and we found that the cell growth was not significantly inhibited. This result indicated that weak expression of *sacB* occurred because the *argC* promoter was not suitable for *E. coli*. Next, the recombinant plasmid was transformed into *C. crenatum* SYPA5-5 and *C. glutamicum* ATCC 13032. As shown in [Figures 4B,C](#F4){ref-type="fig"}, the ARG-Select biosensor in *C. glutamicum* ATCC 13032 with functional ArgR did not cause lethality in cells, whereas no *C. crenatum* SYPA5-5 cells could survive under 10% sucrose pressure. Therefore, the intracellular ArgR could affect cell lethality with *sacB* expression via the regulation of the ARG-Select biosensor. Subsequently, the *PC-sacB* plasmid was transformed into the recombinant strain of *C. glutamicum* ATCC 13032/Δ*argR*, and *sacB* expression led to the complete lethality of cells. The above results showed that our ARG-Select biosensor system could work well in *C. crenatum* SYPA5-5 for the inactivation of *argR*. However, when this ARG-Select biosensor was applied to other *Corynebacterium* species, the deprivation of the background *argR* gene in the strain eliminated the original repression of *sacB* under the *argC* promoter.

![Growth performance of different strains on agar plates containing 10% sucrose. **(A)** *E. coli*, **(B)** *C. glutamicum* ATCC 13032, and **(C)** *C. crenatum* SYPA5-5. The positive control carrying an empty plasmid is on the left, and the strain carrying the *PC-sacB* plasmid is on the right.](fbioe-08-00175-g004){#F4}

Relationship Between Cell Growth and [L]{.smallcaps}-Arginine Production {#S3.SS5}
------------------------------------------------------------------------

The relationship between cell growth and [L]{.smallcaps}-arginine production was further verified in the *sacB*-based ARG-Select biosensor. The strain was mutagenized by ARTP and then cultivated on preliminary screening plates containing IPTG and 10% sucrose. A total of 372 large colonies (colony diameter ≥1.20 mm) grew on the plate, and they were randomly picked with 200 small colonies (colony diameter ≤0.80 mm) to determine the [L]{.smallcaps}-arginine production in 24-deep-well plates. An obvious difference in [L]{.smallcaps}-arginine production was found between large and small colonies ([Figure 5A](#F5){ref-type="fig"}). Most of the small colonies could only produce 1.85--2.40 g L^--1^ of [L]{.smallcaps}-arginine, and they could not produce more than 2.45 g L^--1^ of [L]{.smallcaps}-arginine, whereas most of the large colonies produced 2.55--2.79 g L^--1^ of [L]{.smallcaps}-arginine, and they could not produce less than 2.37 g L^--1^. This result demonstrated that the [L]{.smallcaps}-arginine yield of large colonies was higher than that of small colonies. Moreover, five large (L1, L2, L3, L4, and L5) and five small (S1, S2, S3, S4, and S5) colonies were cultivated to obtain the growth curves ([Figure 5B](#F5){ref-type="fig"}); the cell density (OD~600~) was measured every 24 h. As expected, different growth rates were shown between the large and small colonies, and strains with high [L]{.smallcaps}-arginine production showed a fast growth rate ([Table 3](#T3){ref-type="table"}). Therefore, it can be inferred that [L]{.smallcaps}-arginine production is closely related to cell growth in the ARG-Select biosensor. Instead of sophisticated analytical methods such as HPLC or chemical coloring, the mutagenized strains with high [L]{.smallcaps}-arginine yield can simply be selected by cell growth, which greatly simplifies the operation methods and steps.

![**(A)** Colony sizes of strains carrying the pSenArg-*sacB* plasmid on fermentation medium plates containing 10% sucrose. The left side shows a non-mutagenized parent strain, and the right side shows mixed mutagenized strains including high [L]{.smallcaps}-arginine producing strains, medium [L]{.smallcaps}-arginine producing strains, and low [L]{.smallcaps}-arginine producing strains. **(B)** Growth curves of large and small mutagenized strains. The black square line is the control parent strain. Strains L1, L2, L3, L4, and L5 are large strains, and S1, S2, S3, S4, and S5 are small strains.](fbioe-08-00175-g005){#F5}

###### 

Maximum growth rate and [L]{.smallcaps}-arginine yield of the 10 large and small mutagenized strains.

  **Strains**                      **Control**     **L1**          **L2**          **L3**          **L4**          **L5**          **S1**          **S2**          **S3**          **S4**          **S5**
  -------------------------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- ---------------
  Maximum growth rate (h^--1^)     0.031 ± 0.002   0.043 ± 0.004   0.044 ± 0.002   0.039 ± 0.003   0.050 ± 0.002   0.049 ± 0.003   0.026 ± 0.002   0.026 ± 0.001   0.023 ± 0.001   0.029 ± 0.003   0.020 ± 0.004
  [L]{.smallcaps}-Arginine (g/L)   2.44 ± 0.11     2.67 ± 0.12     2.78 ± 0.13     2.56 ± 0.13     2.89 ± 0.14     2.88 ± 0.12     1.85 ± 0.12     1.88 ± 0.10     1.75 ± 0.13     2.28 ± 0.12     1.59 ± 0.12

Optimization of the Sensitivity of the ArgR Regulator to [L]{.smallcaps}-Arginine {#S3.SS6}
---------------------------------------------------------------------------------

Since strains with high [L]{.smallcaps}-arginine production could reach growth limitation on 10% sucrose plates, the sensitivity of the ArgR protein to [L]{.smallcaps}-arginine was decreased so that the ArgR protein could only be activated by higher [L]{.smallcaps}-arginine concentrations. First, the amino acid sequence of ArgR was submitted to SWISS-MODEL to predict the structure model ([Figure 6A](#F6){ref-type="fig"}). The crystal structure of the protein (PDB: 6A2Q) was used as a template for modeling, and 171 residues (53.8% of the sequence) were modeled using the single highest scoring template.

![**(A)** Structural characterization of the ArgR protein. An overview of the ArgR--arginine complex is shown at the top of the image. The binding pocket of the wild type is on the bottom left, and the mutated strain is on the bottom right; the green stick represents the [L]{.smallcaps}-arginine molecule. **(B)** Relative transcription level of the reporter gene *sacB* in the mutant strains S127I, D146E, and D146L at an [L]{.smallcaps}-arginine concentration of 60 mM.](fbioe-08-00175-g006){#F6}

The molecular structure of ArgR was introduced to search for a mutation site that could cause ArgR to be insensitive to [L]{.smallcaps}-arginine. Residues S127 and D146 within the binding pocket were replaced by other amino acids. Finally, RT-qPCR was used to analyze the *sacB* expression in the site-saturation libraries. When 60 mM of [L]{.smallcaps}-arginine was added, some mutants showed changes in sensitivity. S127 was replaced by [L]{.smallcaps}-isoleucine, and D146 was replaced by [L]{.smallcaps}-glutamate and [L]{.smallcaps}-leucine. The expression of *sacB* was decreased by 2.38- and 1.27-fold for the D146E and D146L mutants, respectively, compared to the wild type, and expression was increased by 2.26-fold for the S127I mutant ([Figure 6B](#F6){ref-type="fig"}). Therefore, insensitivity of ArgR to [L]{.smallcaps}-arginine was achieved by the mutant of S127I. The molecular structure simulation of S127I showed that the binding pocket of ArgR to [L]{.smallcaps}-arginine was diminished, which could increase the [L]{.smallcaps}-arginine screening limitation and improve the screening efficiency.

Improvement of [L]{.smallcaps}-Arginine Production Based on the *sacB* Reporter Gene {#S3.SS7}
------------------------------------------------------------------------------------

For the [L]{.smallcaps}-arginine high-producing strain Cc6, the ARG-Select biosensor could be used to screen increased [L]{.smallcaps}-arginine producers. Based on the pSenArg-*sacB* biosensor plasmid, the *C. crenatum* SYPA5-5 and Cc6 strains were treated with ARTP mutagenesis to increase the [L]{.smallcaps}-arginine production. Mutagen-treated cells of the two strains were cultivated on preliminary screening plates for 48 h. For *C. crenatum* SYPA5-5, approximately 1,994 colonies grew on the plates, which were selected from the original 100,000 mutant cells. Because of the relationship between cell growth and [L]{.smallcaps}-arginine production, 18.7% of larger colonies were picked, and consequently, 372 large colonies were cultivated in 24-deep-well plates for 48 h ([Figure 7A](#F7){ref-type="fig"}). The Sakaguchi reagent spectrophotometric method was used for [L]{.smallcaps}-arginine determination. Then, 14 mutant strains showed 10% increased [L]{.smallcaps}-arginine production, and the HArg1 strain could produce 2.89 g L^--1^ of [L]{.smallcaps}-arginine. The [L]{.smallcaps}-arginine yields of shake-flask fermentation of the 14 mutant strains were further confirmed by HPLC ([Figure 7B](#F7){ref-type="fig"}). The HArg1 strain showed a stable [L]{.smallcaps}-arginine yield of 35.9 ± 2.0 g L^--1^, which represented a 20.8% improvement.

![**(A)** [L]{.smallcaps}-Arginine yield of 372 larger mutant colonies of *C. crenatum* SYPA5-5 in 24-deep-well plates. **(B)** [L]{.smallcaps}-Arginine yield of the top 10% of mutant strains of *C. crenatum* SYPA5-5 in shake-flask fermentation. Statistically significantly increased [L]{.smallcaps}-arginine production are marked with asterisks, which were calculated by Student's unpaired *t*-test (^∗^*P* ≤ 0.05; ^∗∗^*P* ≤ 0.01; ^∗∗∗^ *P* ≤ 0.001). **(C)** [L]{.smallcaps}-Arginine yield of 189 larger mutant colonies of Cc6 in 24-deep-well plates. **(D)** [L]{.smallcaps}-Arginine yield of the top 10% of mutant strains of Cc6 in shake-flask fermentation. Statistically significantly increased [L]{.smallcaps}-arginine production are marked with asterisks, which were calculated by Student's unpaired *t*-test (^∗^*P* ≤ 0.05; ^∗∗^*P* ≤ 0.01).](fbioe-08-00175-g007){#F7}

Similarly, for the Cc6 strain, approximately 1,852 colonies grew on sucrose plates, and only 189 large colonies were cultivated in 24-deep-well plates ([Figure 7C](#F7){ref-type="fig"}); 10 strains exhibited a 10% increase in [L]{.smallcaps}-arginine production. For the shake-flask fermentation of the Cc6 strain, the DArg36 strain showed the highest [L]{.smallcaps}-arginine production, which was increased by 12.9%, and could produce 47.9 ± 1.7 g L^--1^ of [L]{.smallcaps}-arginine ([Figure 7D](#F7){ref-type="fig"}).

Fed-Batch Fermentation of the HArg1 and DArg36 Strains {#S3.SS8}
------------------------------------------------------

The [L]{.smallcaps}-arginine production performances of the HArg1 and DArg36 strains were further investigated in 5-L bioreactors. Fed-batch cultures were performed to examine the performance of the mutant strains for [L]{.smallcaps}-arginine production over 96 h of fermentation. As shown in [Figure 8](#F8){ref-type="fig"}, for the HArg1 strain, cell growth increased to an OD~600~ of 27.8 from 22.3 within 96 h. Because no sucrose was added, the cell growth of DArg36 was OD~600~ = 29.4, similar to the original Cc6 strain OD~600~ = 30.3. [L]{.smallcaps}-Arginine production of both the HArg1 and DArg36 strains was improved, and the glucose consumption was increased. The [L]{.smallcaps}-arginine production of HArg1 was 60.7 g L^--1^, which was increased by 44.5%, the productivity was 0.63 g L^--1^ h^--1^, the glucose consumption was 239.9 g L^--1^, and the [L]{.smallcaps}-arginine yield on glucose was 0.253 g g^--1^. The [L]{.smallcaps}-arginine production of the DArg36 strain was 95.5 g L^--1^, which was increased by 13.5%, the productivity was 0.99 g L^--1^ h^--1^, the glucose consumption was 348.7 g L^--1^, and the [L]{.smallcaps}-arginine yield on glucose was 0.273 g g^--1^. These results demonstrated that the ARG-Select biosensor was capable of obtaining hyperproducing strains with high efficiency.

![**(A)** Fed-batch fermentation of *C. crenatum* SYPA5-5. **(B)** Fed-batch fermentation of the HArg1 strain. **(C)** Fed-batch fermentation of Cc6. **(D)** Fed-batch fermentation of the DArg36 strain. Symbols denote: [L]{.smallcaps}-arginine (red squares), glucose (green circles), and OD~600~ (blue triangles).](fbioe-08-00175-g008){#F8}

Discussion {#S4}
==========

Strains treated by mutagenesis can generate a large number of mutants. Screens and selections are the key components to obtain desired strains ([@B23]). In recent years, an increasing focus has been placed on biosensors for high-throughput screening of hyperproducing strains; strains can be directly selected by the output of reporter gene. Here, we used an ARG-Select biosensor to screen high [L]{.smallcaps}-arginine producers of *C. crenatum* SYPA5-5, and this biosensor mainly consists of the repressor protein of ArgR and its corresponding *argC* promoter. Using *sacB* as the reporter gene, it can provide the strain with an output of bacterial growth in the presence of 10% sucrose. Therefore, the ARG-Select biosensor could translate the intracellular product level into a detectable output of bacterial growth. Because high [L]{.smallcaps}-arginine producing strains could reach the growth limitation on sucrose plates, site-saturation mutagenesis was applied to ArgR to decrease the sensitivity to [L]{.smallcaps}-arginine. In the ARG-Select biosensor system, negative mutant strains cannot survive under sucrose pressure, and colonies with sizes larger than the parent strain were used to measure the [L]{.smallcaps}-arginine production, greatly reducing the workload by a simple manipulation.

Previously, metabolic engineering strategies were used to balance enzyme expression levels and optimize genes encoding key enzymes ([@B4]; [@B31]). In *C. glutamicum* sp., a series of enzymes are involved in the [L]{.smallcaps}-arginine synthesis pathway. The expression of these enzymes is closely related to [L]{.smallcaps}-arginine production. For example, the overexpression of the *arg* cluster in *C. crenatum* SYPA5-5 by its native promoter can increase the [L]{.smallcaps}-arginine yield by approximately 24.9% ([@B37]). The co-expression of the *argGH* transcript in *C. crenatum* SYPA5-5 can improve [L]{.smallcaps}-arginine production by 9.5% ([@B42]).

However, the limitation of these enzymes makes it difficult for this strategy to achieve a higher level of metabolite production ([@B29]). Therefore, the strategy of random mutagenesis is still a desired approach that has a greater possibility of obtaining high-level production strains ([@B7]; [@B23]), and biosensors have emerged as a high-throughput screening method to obtain hyperproducing strains. The biosensors are mainly based on recognition elements that can respond to specific metabolites, such as TFs ([@B18]; [@B12]), riboswitches ([@B3]), fluorescence resonance energy transfer (FRET) ([@B40]), and pressure-sensitive promoters ([@B33]). Among these elements, TFs play a major role in controlling gene expression at the level of transcription, and TFs-based biosensors have been widely applied to obtain high-yield strains by monitoring intracellular metabolite production from a measurable output ([@B6]).

In this study, the increased [L]{.smallcaps}-arginine production of *C. crenatum* SYPA5-5 and Cc6 strains demonstrated the effectiveness of the biosensor system. This is a valuable high-throughput screening method that can bridge the gap between a detectable signal and metabolite production. Furthermore, we believe that the [L]{.smallcaps}-arginine production of our strains still has an improvement space. Adaptive laboratory evolution (ALE) will be applied to increase the [L]{.smallcaps}-arginine production, which is achieved by further mutation and screening.
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